NID2 and breast cancer: Studies have also confirmed the diagnostic efficacy of TWIST1 and NID2 biomarkers, which exhibit high sensitivity and specificity for BC detection (Fantony et al., 2015; Abern et al., 2014; Renard et al., 2010).